Paper36979861
From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications.
Boccatonda A and 8 others. Biomedicines, 2023. Cited by 91 papers, by iCite.
Cite this record
ConductScience Library. From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications. Papers, record 36979861. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36979861
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06585982 | Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile Analysis | Background |
Source ClinicalTrials.gov
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11961152 | Nonalcoholic fatty liver disease. | N Engl J Med | 2002 | https://conductscience.org/library/papers/11961152 | PubMed |
| 2 | 35639744 | A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis. | PLoS One | 2022 | https://conductscience.org/library/papers/35639744 | PubMed |
| 3 | 27072166 | Oxidative Stress Modulation Through Habitual Physical Activity. | Curr Pharm Des | 2016 | https://conductscience.org/library/papers/27072166 | PubMed |
| 4 | 29981771 | An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases. | Prog Cardiovasc Dis | 2018 | https://conductscience.org/library/papers/29981771 | PubMed |
| 5 | 18317565 | Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. | J Clin Invest | 2008 | https://conductscience.org/library/papers/18317565 | PubMed |
| 6 | 32707340 | Association of Hepatic Steatosis With Major Adverse Cardiovascular Events, Independent of Coronary Artery Disease. | Clin Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/32707340 | PubMed |
| 7 | 33162743 | Association between cardiac conduction defect and nonalcoholic fatty liver disease: a systematic review and meta-analysis. | Ann Gastroenterol | 2020 | https://conductscience.org/library/papers/33162743 | PubMed |
| 8 | 27732328 | Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study. | J Clin Endocrinol Metab | 2017 | https://conductscience.org/library/papers/27732328 | PubMed |
| 9 | 30079133 | Associations between nonalcoholic fatty liver disease and ischemic stroke. | World J Hepatol | 2018 | https://conductscience.org/library/papers/30079133 | PubMed |
| 10 | 30731283 | Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps. | Atherosclerosis | 2019 | https://conductscience.org/library/papers/30731283 | PubMed |
| 11 | 15920069 | Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study. | Diabetes Care | 2005 | https://conductscience.org/library/papers/15920069 | PubMed |
| 12 | 31965072 | Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study. | Int J Obes (Lond) | 2020 | https://conductscience.org/library/papers/31965072 | PubMed |
| 13 | 26044182 | Arterial stiffness and sedentary lifestyle: Role of oxidative stress. | Vascul Pharmacol | 2016 | https://conductscience.org/library/papers/26044182 | PubMed |
| 14 | 33530440 | NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations. | J Clin Med | 2021 | https://conductscience.org/library/papers/33530440 | PubMed |
| 15 | 15920328 | Should nonalcoholic fatty liver disease be renamed? | Dig Dis | 2005 | https://conductscience.org/library/papers/15920328 | PubMed |
| 16 | 30122305 | Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. | Lancet | 2018 | https://conductscience.org/library/papers/30122305 | PubMed |
| 17 | 35693392 | Is it necessary to target lipid metabolism in different organs for effective treatment of NASH?-the results of the Pan-PPAR Lanifibranor trial. | Hepatobiliary Surg Nutr | 2022 | https://conductscience.org/library/papers/35693392 | PubMed |
| 18 | 36577468 | Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease. | Ann Hepatol | 2023 | https://conductscience.org/library/papers/36577468 | PubMed |
| 19 | 33038502 | A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study. | Contemp Clin Trials | 2020 | https://conductscience.org/library/papers/33038502 | PubMed |
| 20 | 31455011 | Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications. | Int J Environ Res Public Health | 2019 | https://conductscience.org/library/papers/31455011 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42789307 | An RNA thermogenic therapy to preserve lean mass and enhance metabolic health during GLP-1 weight loss. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42789307 | PubMed |
| 42665350 | Perspectives of gastroenterologists on the evolving epidemiology and management of non-alcoholic fatty liver disease in Pakistan: a qualitative study. | BMJ Open | 2026 | https://conductscience.org/library/papers/42665350 | PubMed |
| 42290708 | Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study. | Ther Adv Endocrinol Metab | 2026 | https://conductscience.org/library/papers/42290708 | PubMed |
| 42075067 | Effect of 4-Week Consumption of "Navelina" Oranges on Serum Lipid Profile in Patients with MASLD: Evidence from a Randomized Clinical Trial. | Nutrients | 2026 | https://conductscience.org/library/papers/42075067 | PubMed |
| 41972947 | Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus. | Ann Med | 2026 | https://conductscience.org/library/papers/41972947 | PubMed |
| 41915720 | Large language model detects previously undiagnosed heart failure with preserved ejection fraction in patients with metabolic-associated fatty liver disease: A multicenter cohort study. | PLOS Digit Health | 2026 | https://conductscience.org/library/papers/41915720 | PubMed |
| 41828076 | Rare Causes of Portal Vein Thrombosis and Occlusion: A Narrative Review. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41828076 | PubMed |
| 41728070 | MetALD: decoding the evolution of steatotic liver disease nomenclature and implications for clinical practice and beyond. | Gastroenterol Rep (Oxf) | 2026 | https://conductscience.org/library/papers/41728070 | PubMed |
| 41718836 | Metabolomic characteristics and mechanisms of subgingival plaque in MASLD patients with periodontitis. | Metabolomics | 2026 | https://conductscience.org/library/papers/41718836 | PubMed |
| 41590615 | Antioxidant Clove Extract Inhibits Lipid Droplet Accumulation and Lipid Oxidation in Hepatocytes. | Metabolites | 2025 | https://conductscience.org/library/papers/41590615 | PubMed |
| 41479860 | Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease. | World J Gastrointest Pathophysiol | 2025 | https://conductscience.org/library/papers/41479860 | PubMed |
| 41295331 | Serum Extracellular Vesicles as Pathogenetic Signals in Obese and Lean Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. | Metabolites | 2025 | https://conductscience.org/library/papers/41295331 | PubMed |
| 41245406 | The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio is associated with early onset type 2 diabetes with NAFLD: a cross-sectional study in China. | Front Nutr | 2025 | https://conductscience.org/library/papers/41245406 | PubMed |
| 41100462 | Nonlinear association between TyG-BMI and MAFLD: A cross-sectional study. | PLoS One | 2025 | https://conductscience.org/library/papers/41100462 | PubMed |
| 40954485 | Screening for metabolic-associated fatty liver disease in type 2 diabetes patients using non-invasive scores and ultrasound: a cross-sectional study in Egypt. | BMC Gastroenterol | 2025 | https://conductscience.org/library/papers/40954485 | PubMed |
| 40897824 | A potential age-independent MASLD-related liver fibrosis index based on metabolic profiling. | Sci Rep | 2025 | https://conductscience.org/library/papers/40897824 | PubMed |
| 40886507 | Exposure to low levels of hexavalent chromium in drinking water alters diet-induced steatotic liver disease in male rats. | J Trace Elem Med Biol | 2025 | https://conductscience.org/library/papers/40886507 | PubMed |
| 40863135 | Whey Proteins and Metabolic Dysfunction-Associated Steatotic Liver Disease Features: Evolving the Current Knowledge and Future Trends. | Metabolites | 2025 | https://conductscience.org/library/papers/40863135 | PubMed |
| 40860752 | MAFLD: A Comprehensive Review of the Link Between Metabolic Dysfunction and Cardiovascular Risk. | Hepat Med | 2025 | https://conductscience.org/library/papers/40860752 | PubMed |
| 40842749 | Detecting Portal Venous Blood Flow in Metabolic Dysfunction-Associated Fatty Liver Disease Using Non-Invasive Doppler Ultrasound. | Cureus | 2025 | https://conductscience.org/library/papers/40842749 | PubMed |
Genes25
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36979861
GET https://conductscience.org/api/papers/v1/36979861/references?page=2